Data Science Funding Announcements & Notices

Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.

Title FOA Organization Release Date Expire Date Purpose
Second Round of the NIH Applicant Assistance Program (AAP) for New or Previously Unawarded Small Businesses NOT-CA-18-072 NCI N/A Second Round the NIH Applicant Assistance Program AAP) New Previously Unawarded Small Businesses Notice Number: NOT-CA-18-072 Key Dates Release Date: 14, 2018 Related Announcements NOT-CA-18-031… More
Notice of Intent to Publish: Funding Opportunity Announcement for Human Immune-Representing Oncology Models for Immuno-Oncology Research (R33 Clinical Trial Optional) NOT-CA-19-047 NCI N/A Notice Intent Publish: Funding Opportunity Announcement Human Immune-Representing Oncology Models Immuno-Oncology Research R33 Clinical Trial Optional) Notice Number: NOT-CA-19-047 Key Dates Release… More
Notice of Expiration of RFA-CA-19-042, "Informatics Technology for Cancer Research Education Resource (UE5 Clinical Trial Not Allowed)" NOT-CA-20-060 NCI N/A Notice Expiration RFA-CA-19-042, Informatics Technology Cancer Research Education Resource UE5 Clinical Trial Allowed)" Notice Number: NOT-CA-20-060 Key Dates Release Date: 6, 2020 Related… More
Notice of Availability of Administrative Supplements for NCI Grant and Cooperative Agreement Awards to Support Pediatric Cancer Control Research Across the Lifespan (Admin Supp Clinical Trial Optional) NOT-CA-18-088 NCI N/A Notice Availability Administrative Supplements NCI Grant Cooperative Agreement Awards Support Pediatric Cancer Control Research Across Lifespan Admin Supp Clinical Trial Optional) Notice Number: NOT… More
Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) PAR-21-279 NCI The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NCI R25 program is to support educational activities… More
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) PAR-21-128 NCI This Funding Opportunity Announcement (FOA) represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to… More
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) RFA-CA-21-011 NCI The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI P01 program projects. The… More
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) PAR-20-313 NCI Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications to support the validation of molecular/cellular/imaging markers (referred to as "… More
Clinical Translation of Activated Optical Fluorescence Methods and Technologies for Sensitive Cancer Detection in Vivo (R01 Clinical Trial Optional) PAR-20-295 NCI [The purpose of this PAR is to bring a highly sensitivity imaging technology capable of locating very small (1-3 mm) tumors in vivo to clinical utility. Under this funding opportunity, NCI solicits… More
Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed) PAR-20-116 NCI This Funding Opportunity Announcement (FOA), entitled "Toward Translation of Nanotechnology Cancer Interventions" (TTNCI), encourages applications for advanced pre-clinical research,… More
Updated: